anti-CA 15-3 antibody product blog
Tags: Antibody; Monoclonal Antibody; CA 15-3; anti-CA 15-3 antibody;
The CA 15-3 n/a (Catalog #MBS5305308) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse Monoclonal CA 15-3 antibody reacts with Specific against breast cancer Ag. No cross-reactivity against CA125, CA 19-9, CA 72-4, AFP, CEA, Normal Serum (by ELISA). and may cross-react with other species as described in the data sheet. MyBioSource\'s CA 15-3 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB). Researchers should empirically determine the suitability of the CA 15-3 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Mouse Monoclonal CA 15-3 antibody with the following immunoassay(s):
Immunocytochemistry (ICC) (MCF7 cells coated on 24 well plate with methanol:acetone (1:3)fixative)
Immunohistochemistry (IHC) (MCF7 cells coated on 24 well plate withparaformaldehydefixative)
Immunogen: CA 15-3 antibody was raised in Mouse using Human Breast cancer specific antigen as the immunogen
Affinity Constant: 3.1 x 10^-9. Dry Ice Shipment: Extra charge may be applied to your shipping cost as dry ice is required to ship this product. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CA 15-3 are readily searchable from our website. Different antibodies against the same target such as CA 15-3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.